文献速递慢阻肺

慢阻肺控制状态对急性加重风险的预测价值:一项国际前瞻性研究

Predictive value of control of COPD for risk of exacerbations: An international, prospective study.
PubMed 文献 · Respirology · 2020-04-06

该国际多中心前瞻性研究纳入307例慢阻肺患者,按临床标准或CAT评分在基线分为控制/未控制,随访18个月。以临床标准判定为控制者随访期间急性加重次数显著少于未控制者(1.1 vs 2.6,P<0.001),且临床标准对急性加重的预测优于CAT标准(AUC 0.67 vs 0.57)。

要点

  • 按简易临床标准判定的慢阻肺控制状态可预测未来急性加重风险
  • 临床标准控制的患者首次急性加重时间显著延长
  • 临床标准预测效能优于CAT评分,可在每次就诊时评估

核心结论

  • 按简易临床标准定义的慢阻肺控制状态可预测未来急性加重风险及距下次急性加重的时间。
  • 控制概念可作为指南初始治疗推荐的补充,在每次临床就诊时使用。

研究设计与样本

  • 国际、多中心、前瞻性研究,旨在验证慢阻肺控制概念。
  • 共分析307例慢阻肺患者,平均年龄68.6岁,平均FEV1%为52.5%。
  • 基线按临床标准或CAT评分分为控制/未控制,随访18个月。
  • 主要结局为18个月随访期间中度及重度急性加重或死亡的复合终点发生率差异。

主要发现

  • 按临床标准判定为控制者占65%,按CAT判定为控制者占37.9%。
  • 随访期间控制者急性加重显著更少:临床标准1.1 vs 2.6(P<0.001);CAT标准1.1 vs 1.9(P=0.014)。
  • 仅按临床标准判定的控制者首次急性加重时间显著延长(中位93天,IQR 63;242 vs 274天,IQR 221;497天;P<0.001)。
  • 临床标准控制状态对急性加重的预测优于CAT标准(AUC 0.67 vs 0.57)。

关键数值与推荐

  • 控制判定采用临床标准或CAT评分两种方式。
  • 控制者与未控制者急性加重次数比较:临床标准1.1 vs 2.6(P<0.001),CAT标准1.1 vs 1.9(P=0.014)。
  • 预测效能AUC:临床标准0.67,CAT标准0.57。

临床怎么用

  • 可在每次临床就诊时用简易临床标准评估慢阻肺控制状态,作为指南初始治疗推荐的补充。
  • 控制状态有助于识别未来急性加重高风险患者并指导治疗决策。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND OBJECTIVE: The concept of clinical control in COPD has been developed to help in treatment decisions, but it requires validation in prospective studies. METHODS: This international, multicentre, prospective study aimed to validate the concept of control in COPD. Patients with COPD were classified as controlled/uncontrolled by clinical criteria or CAT scores at baseline and followed up for 18 months. The main outcome was the difference in rate of a composite endpoint of moderate and severe exacerbations or death over the 18-month follow-up period. RESULTS: A total of 307 patients were analysed (mean age = 68.6 years and mean FEV1 % = 52.5%). Up to 65% and 37.9% of patients were classified as controlled by clinical criteria or CAT, respectively. Controlled patients had significantly less exacerbations during follow-up (by clinical criteria: 1.1 vs 2.6, P < 0.001; by CAT: 1.1 vs 1.9, P = 0.014). Time to first exacerbation was significantly prolonged for patients controlled by clinical criteria only (median: 93 days, IQR: 63; 242 vs 274 days, IQR: 221; 497 days; P < 0.001). Control status by clinical criteria was a better predictor of exacerbations compared to CAT criteria (AUC: 0.67 vs 0.57). CONCLUSION: Control status, defined by easy-to-obtain clinical criteria, is predictive of future exacerbation risk and time to the next exacerbation. The concept of control can be used in clinical practice at each clinical visit as a complement to the current recommendations of initial treatment proposed by guidelines.

来源:Respirology,查看原文。版权归原作者所有。

引用

  1. Miravitlles M, Sliwinski P, Rhee CK, et al. Predictive value of control of COPD for risk of exacerbations: An international, prospective study. Respirology. 2020. PMID: 32249487. doi:10.1111/resp.13811

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。